Rivastigmine in Parkinson's Disease Dementia: A Viewpoint by Murat Emre

Author： Emre Murat  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.20, Iss.9, 2006-01, pp. : 748-750

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivastigmine in Parkinson's disease dementia

By Chitnis Shilpa   Rao Jayaraman  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 941-955

Informa Healthcare

Access to resources Recommend Favorite

Rivastigmine: In Parkinson's Disease Dementia

By Siddiqui M. Asif A.   Wagstaff Antona J.  

CNS Drugs, Vol. 20, Iss. 9, 2006-01 ,pp. : 739-747

Adis International

Access to resources Recommend Favorite

Rivastigmine in Parkinson's Disease Dementia: Profile Report

By Siddiqui M. Asif A.   Wagstaff Antona J.  

Drugs & Aging, Vol. 24, Iss. 3, 2007-01 ,pp. : 255-259

Adis International

Access to resources Recommend Favorite

Rivastigmine effective in dementia associated with Parkinson's disease

By  

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Rivastigmine in Patients with Parkinson's Disease Dementia

By Willan Andrew R.  

PharmacoEconomics, Vol. 24, Iss. 1, 2006-01 ,pp. : 93-106

Adis International

Access to resources Recommend Favorite